12 years together. The experience of using Magic Staff Forte for the treatment of erektil dysfunktion ED

##plugins.themes.bootstrap3.article.sidebar##

PDF (Русский)
Published: Apr 27, 2018
DOI: https://doi.org/10.30841/2307-5090.1.2018.143037
Keywords:
erectile dysfunction, type 5 PDE blockers, Magic Staff Forte, penile doplerography, tional Index of Erectile Function (IIEF-5) questionnaire,

##plugins.themes.bootstrap3.article.main##

В. Г. Мігов
State Establishment «Institute of Urology of the National Academy of Medical Sciences of Ukraine», Ukraine
В. В. Білоголовська
State Establishment «Institute of Urology of the National Academy of Medical Sciences of Ukraine», Ukraine

Abstract

A five-year, prolonged-time study of patients with corporal venoocclusive dysfunction, for treatment of which was used by Magic Staff Forte, was performed with a frequency of 2 months twice a year at even intervals. The results show the effectiveness of the treatment schemes presented.

##plugins.themes.bootstrap3.article.details##

How to Cite
Мігов, В. Г., & Білоголовська, В. В. (2018). 12 years together. The experience of using Magic Staff Forte for the treatment of erektil dysfunktion ED. Health of Man, (1), 70–76. https://doi.org/10.30841/2307-5090.1.2018.143037
Issue
No. 1 (2018)
Section
Sexology and andrology
Copyright (c) 2020 В. Г. Мігов, В. В. Білоголовська

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.

Author Biographies

В. Г. Мігов, State Establishment «Institute of Urology of the National Academy of Medical Sciences of Ukraine»

Vitalii G. Migov,

Department of Sexopathology and Andrology

В. В. Білоголовська, State Establishment «Institute of Urology of the National Academy of Medical Sciences of Ukraine»

Valentyna V. Bilogolovskaja

References

Иремашвили В.В. Новый подход к лечению больных эректильной дисфункцией: постоянный прием ингибиторов фосфодиэстеразы 5 типа / В.В. Иремашвили // Русский Медицинский Журнал. – 2008. – № 9. – С. 620–624.

Практическая андрология / Под ред. С.Ю. Калинченко, И.А. Тюзикова. – М.: Практическая медицина. – 2009. – 280 с.

Урология. Национальное руководство / Под ред. Н.А. Лопаткина. – М.: ГЭОТАР-Медиа. – 2009. – 510 с.

A multicenter, randomized, doubleblind, crossover study to evaluate patient preference between tadalafil and sildenafil / A. von Keitz, J. Rajfer, S. Segal et al. // Eur Urol. – 2006. – Vol. 45. – P. 499–507. https://doi.org/10.1016/j.eururo.2003.11.030

American Urology Association. Erectile Dysfunctions Guidelines Update Panel, June 2007. Chapter 1–10: AUA Guideline on the Management of Erectile Dysfunction: Diagnosis and Treatment Recommendations.

Benet A.E. The epidemiology of erectile dysfunction / A.E. Benet, A. Melman // Urol Clin North Am. – 1995. – Vol. 22 (4). – P. 699–709.

Claes H. Characteristics and expectations of patients with erectile dysfunction: Results of the SCORED study / H. Claes // Int J Impot Res. – 2008. – Vol. 20. – P. 418–424. https://doi.org/10.1038/ijir.2008.7

Erectile Dysfunction: Monitoring Response to Treatment in Clinical Practice – Recommendations of an International Study Panel / J. Mulhall, S.E. Althof, G.B. Brock et al. // Journal of Sexual Medicine. – 2007. – Vol. 4. – P. 448–464. https://doi.org/10.1111/j.1743-6109.2007.00441.x

Grundy S.M. Metabolic syndrome: a multiplex cardiovascular risk factor / S.M. Grundy // J Clin Endocrinol Metab. – 2007. – Vol. 92. – P. 399–404. https://doi.org/10.1210/jc.2006-0513

Mc Murray J.G. Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction / J.G. Mc Murray // Ther Clin Risk Manag. – 2007. – Vol. 3. – P. 975–981.

Paick Jae-Seung. The Efficacy and Safety of Udenafil, a New Selective Phosphodiesterase Type 5 Inhibitor, in Patients with Erectile Dysfunction / Jae-Seung Paick // J Sex Med. – 2008. – Vol. 5. – P. 946–953. https://doi.org/10.1111/j.1743-6109.2007.00723.x

Quality of erections in men treated with flexible-dose sildenafil for erectile dysfunction: multicenter trial with a double-blind, randomized, placebocontrolled phase and an open-label phase / A. Kadioglu, W. Grohmann, A. Depko et al. // J Sex Med. – 2008. – Vol. 5 (3). – P. 726–734. https://doi.org/10.1111/j.1743-6109.2007.00701.x

Seftel A.D. A three-part study to investigate the incidence and potential etiologies of tadalafil-associated back pain or myalgia / A.D. Seftel // International Journal of Impotence Research. – 2005. – Vol. 17. – P. 455–461. https://doi.org/10.1038/sj.ijir.3901374

Taylor J. Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors / J. Taylor // BJU Int. – 2009. – Vol. 103. – P. 1392–1395. https://doi.org/10.1111/j.1464-410X.2008.08328.x

Возіанов О.Ф., Горпинченко І.І. Досвід застосування віагри в Україні / Сексология и андрология. – К., 2000, Вып. 5. – С. 3–5.

Горпинченко И.И. Эректильная дисфункция: диагностика и современные методы лечения // Здоровье мужчины. – 2002. – № 1. – С. 9–11.

Горпинченко И.И., Мирошников Я.О. Эректильная дисфункция. – Л.: «Медицина світу». – C. 88

Горпинченко И.И. Геронтологическая сексопатология: Производственное издание. – Здоровья, 1991. – С. 168.

Rosen R.C., Riley A., Wagner G. et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction // Urology. – 1997. – V. 49. – P. 822–830. http://dx.doi.org/10.1016/S0090-4295(97)00238-0

Бюва Ж. Лечение силденафилом, четырёхлетний опыт // Здоровье мужчины. – 2002. – № 2. – С. 11–13.

Вагнер Г., Грин Р. Импотенция (физиология, психология, хирургия, диагностика и лечение). – М.: Медицина, 1985. – 240 с.